DHZ-24025-80464
2 vaccinations
1 coded response
19 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 432 / OH
- Registered
- 2020-12-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-22
Dose 1 — Moderna
-
2020-12-27
Registered in v-safe
- 2020-12-27
- 2020-12-28
- 2020-12-29
- 2021-01-07
-
2021-01-19
Dose 2 — Moderna
- 2021-01-19
-
2021-01-20
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-21
- 2021-01-22
- 2021-01-23
- 2021-01-25
- 2021-01-26
- 2021-02-02
- 2021-02-09
- 2021-02-16
- 2021-02-23
- 2021-03-02
- 2021-04-20
- 2021-07-20
-
2022-01-19
Survey response — 12 months, dose 2MedDRA: Adenovirus infection, Conjunctivitis, Myalgia, Nasal congestion, Odynophagia, Oropharyngeal pain, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: New symptoms include sore throat/odynophagia, myalgia, conjunctivitis, and nasal congestion. All due to adenovirus (confirmed not COVID19).MedDRA releases: 2024-11 · check-in free text available
-
2022-01-19
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-01-20
-
2022-01-25
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Moderna | |
| 2 | 2021-01-19 | Moderna |
Call center
1 call center case
1 successful
Free text
Release 10 — 12 months, dose 2
Symptoms: New symptoms include sore throat/odynophagia, myalgia, conjunctivitis, and nasal congestion. All due to adenovirus (confirmed not COVID19).
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Adenovirus infection | · | · | ✓ |
| SD | Conjunctivitis | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Odynophagia | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release